Literature DB >> 23035656

Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents.

Anne-Marie Ronchetti, Françoise Isnard, Marc Buffet, Tereza Coman, Norbert-Claude Gorin, Paul Coppo, Laurent Garderet, Sandra Malak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23035656     DOI： 10.3109/10428194.2012.733879

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy.

Authors:  Corey Toocheck; Daniel Pinkhas
Journal:  BMJ Case Rep       Date:  2018-03-09

Review 2.  Clinical Management of Triple-Class Refractory Multiple Myeloma: A Review of Current Strategies and Emerging Therapies.

Authors:  Margaret E Stalker; Tomer M Mark
Journal:  Curr Oncol       Date:  2022-06-23       Impact factor: 3.109

3.  C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma.

Authors:  Vidya Kollu; Sarah L Mott; Rafiullah Khan; Umar Farooq; Yogesh Jethava; Ince Dilek; Guido Tricot
Journal:  Cureus       Date:  2018-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.